The survival time of patients with Gaucher’s disease depends on the type of Gaucher’s disease, the patient’s condition and the treatment, and cannot be generalized. In the case of type I Gaucher disease, which is called non-neurological Gaucher disease, the progression is slow and the patient can survive for a long time after splenectomy with normal intelligence, but growth may be delayed; in the case of type II Gaucher disease, which is neurological Gaucher disease, most patients with type II die within 1 year after the onset of the disease due to secondary infection, but a few patients can survive for more than 2 years; in the case of type III Gaucher disease, the survival time is even shorter due to severe neurological symptoms. In the case of type III Gaucher disease, survival time is even shorter due to more severe neurological symptoms, and death is often due to complications such as infection. The current principles of treatment for Gaucher disease are to reduce the accumulation of toxic substances caused by metabolic defects, to replenish normally required substances, enzymes or genetic medicine. Therefore, although there is no apparently effective drug for this disease, it can be controlled, so patients should adjust their mindset and face it with courage.